
Dodla Dairy Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
No
Order
N/A
Capex
Yes
1 of 4 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- The company targets a consistent value growth of around 15% CAGR on average going forward, acknowledging seasonal fluctuations in the dairy industry (Sunil Reddy).
- H1 FY25 already recorded a 20% top-line growth, suggesting a strong current year with possible normalization in subsequent years.
- Expansion plans include entry and scale-up in Maharashtra with a large integrated plant capable of 10 lakh liters, staged over 15-16 months (BVK Reddy).
- Africa business volumes have increased, with sales volume rising from 1.11 lakh liters/day in FY24 to 1.78 lakh liters/day in H1 FY25; however, margins dip seasonally (BVK Reddy).
- Value-added products (VAP) sales continue growing strongly; they constituted 39-40% of sales and are expected to sustain in this range (Sunil Reddy).
- Milk sales volumes in India grew from 13.47 lakh liters/day (FY24) to 14.13 lakh liters/day in H1 FY25, indicating volume growth momentum (BVK Reddy).
- The company emphasizes maintaining EBITDA margins in the 9-10% range while focusing on absolute earnings growth.
See what Dodla Dairy management said on margin guidance — free account, 30 seconds.
Fundraise plans
No- There is no specific mention of immediate or planned new fundraising through debt or equity.
- The company has substantial cash on its balance sheet and is currently deploying cash for expansion, notably the Maharashtra plant.
- Management is open to acquisitions but none are finalized or imminent.
- Focus is on organic growth and capex, with Maharashtra plant capex spread over FY25 and FY26.
- Dividends have been declared, including an interim dividend of INR 3 per share, and the company plans to maintain dividend payouts.
- No explicit indication of raising fresh equity or debt in the near term was provided during the call.
See what Dodla Dairy management said on order book — free account, 30 seconds.
Capex plans
Yes- Maharashtra Plant: Dodla Dairy has acquired 35 acres of land in Maharashtra for an integrated manufacturing plant with an initial capacity plan having 2 lakh liters of milk procurement currently, aiming to scale to 7 lakh liters per day over three years.
- Capex Estimate: Overall project cost for Maharashtra is estimated between INR 200 to 250 crores, to be executed in stages over FY25 and FY26.
- Timeline: Civil operations to commence by November 2024, with plant commencement targeted around April 2026; major capex expected in FY26.
- Additional Land: Plans to acquire adjoining land to expand the plant capacity to 10 lakh liters.
- No Major Investments in Africa: No further capex planned currently in Kenya or Uganda; focus on stabilizing operations.
- Ongoing Normal Capex: Regular capex in FY25 around INR 43 crores spent in H1, in line with normal trends.
- Strategic Focus: Potential acquisitions are being explored but no immediate deals finalized.
Track Dodla Dairy — get its next earnings analysis in your feed
How does Dodla Dairy rank vs peers in Food Products?
Pro featureHow does Dodla Dairy rank in Food Products?
Compare Dodla Dairy against every Food Products company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Dodla Dairy's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q4 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Food Products this season
- Sheetal Cool Products Ltd (Q1 FY27)
Revenue from Operations for FY26: ₹366.0 Crores, up 13.9% YoY from ₹321.3 Crores in FY25 (Page 29, 5). Key investor presentation takeaways from Sheetal Cool Pro
- Mukka Proteins Ltd (Q4 FY26)
Q4 FY26 Revenue from Operations:** ₹381.6 Cr . Key concall takeaways from Mukka Proteins Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
- Mukka Proteins Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹489.7 crore . Key concall takeaways from Mukka Proteins Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key concall takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.